John J. Hopfield and Geoffrey E. Hinton were awarded the 2024 Nobel Prize in Physics for developing machine learning technology using artificial neural networks. In Chemistry it was awarded to Demis Hassabis and John…
Continue Reading
What You Should Know:
– Siemens Healthineers and The Ohio State Wexner Medical Center have expanded their long-standing collaboration to establish a 10-year, $105M Value Partnership.
– The strategic alliance aims to drive innovation in medical…
Continue Reading
Patients with rare diseases often experience prolonged diagnostic delays. Ordering appropriate genetic tests is crucial yet challenging, especially for general pediatricians without genetic expertise. Recent American College of Medical Genetics (ACMG) guidelines embrace early…
Continue Reading
A fundamental goal of evaluating the performance of a clinical model is to ensure it performs well across a diverse intended patient population. A primary challenge is that the data used in model development…
Continue Reading
What You Should Know:
– Thoughtful AI, an innovator in AI-powered revenue cycle transformation, has announced the launch of its comprehensive team of specialized AI Agents for revenue cycle management (RCM).
– By optimizing back-office operations…
Continue Reading
We developed an interpretable model, BOUND (Bayesian netwOrk for large-scale lUng caNcer Digital prescreening), using a comprehensive EHR dataset from the China to improve lung cancer detection rates. BOUND employs Bayesian network uncertainty inference,…
Continue Reading
What You Should Know:
– Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients, announced today a further equity investment from NVentures, NVIDIA’s venture capital arm.
– This investment is in addition…
Continue Reading
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
Ballad Health, a healthcare system, is using AI-based patient safety company MedAware’s AI-powered medication safety monitoring platform to allow real-time personalized risk monitoring for acute care patients.The acute care pharmacy team at Ballad Health…
Continue Reading
At the HLTH conference in Las Vegas, MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed executives who offered their insights on the shifting healthcare landscape. Their technologies span a variety of applications…
Continue Reading
